Macy Burkhart|
Cheryl Reese joined the MJ team as a pharmacy operations specialist within our Benefits Consulting department. With a keen eye for data analysis, Cheryl identifies trends that lead to cost-effective medication solutions while providing comprehensive support and education to our clients. Passionate about enhancing healthcare access, Cheryl collaborates effectively with various team members to ensure seamless integration of pharmacy services for our clients.
Prior to her current role, Cheryl obtained business and leadership experience from various companies, such as Delta Airlines, Multnomah University & Oklahoma Wesleyan University. Channeling that experience, she served as a member of the leadership team that started Cedarville University School of Pharmacy. This work led her to realizing her passion of pharmacy benefit consulting. Cheryl brings with her over a decade of experience in PBM consulting and analytics. Her institutional knowledge and client-centric approach make her a great fit for the MJ team and our clients.
Related Blogs
Health Care Industry Trends to Watch in 2026
The MJ CompaniesHealth care organizations enter 2026 facing numerous operational, financial and liability pressures, including labor shortages, inflation, supply chain volatility and the impact of U.S. ...
Read More
2025 Ended with Softest Market Conditions Since 2017 for all Account Sizes & Majority of Lines of Business, The Council’s P/C Market Survey Shows
The MJ CompaniesThe market appeared to move further into the soft part of the insurance market cycle in Q4 2025. Premiums across all account sizes rose ...
Read More
Miles for Miles Helps People With Intellectual and Developmental Disabilities Thrive
Britni ShroutMiles Peck loves school as much for the chance to spend time with his friends as for the classroom experience. He is bracing his ...
Read More
EBSA Updates National Employee Benefit Plan Enforcement Projects for 2026
DeAnn DeckThe Employee Benefits Security Administration (EBSA) announced updates to its national enforcement projects for fiscal year 2026. According to EBSA, these projects highlight areas ...
Read More
The Hard Market Is Shifting—Here’s What That Means for YOU
Adam AdlerFor years, organizations have been told the same thing at renewal: higher costs, fewer options, and little room to negotiate. Now, that message is ...
Read More
Employer Response to Pharma Shifts
Chris AntypasVolatility in the pharmaceutical industry, including the expanding specialty drug pipeline, increased utilization of GLP-1 medications, and persistent supply chain disruptions, are contributing to rising costs ...
Read More